Chinese expert consensus on clinical diagnosis and treatment of breast cancer targeting HER2

The overarching goal of this consensus is to deliver individualized treatment strategies that not only prolong survival but also enhance quality of life, ensuring HER2-positive breast cancer patients receive the most advanced, patient-centered care available.